Drawing for AUROBAC

USPTO serial 79375815

AUROBAC

Reviewed by CopyMark Law Group

Reg. 7525724Status 700Registered
Filing date
Status date
Registration date
Oct 8, 2024
Examiner
PHILLIPS, ALEXANDER J
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with AUROBAC?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Martin M. Zoltick

Martin M. Zoltick Rothwell, Figg, Ernst & Manbeck, PC901 New York Avenue, NWSuite 900Washington, DC 20001

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical and veterinary products, namely pharmaceutical and veterinary preparations for prevention and treatment of infectious diseases and critical care conditions, namely, systemic inflammatory response syndrome (SIRS), sepsis, and septic shock, as well as related diseases and co-morbidities; dietetic food and dietetic substances being preparations for medical or veterinary useACTIVE—
042Scientific and technological services, namely, pharmaceutical drug development services as well as research and design services relating thereto; industrial analysis and research services, namely, research and development of new products for third parties; medical research services; research services in the fields of biology, bacteriology, and chemistry; clinical research in the field of infectious diseases and critical care; Scientific research in the nature of conducting clinical trials for others; development of pharmaceutical productsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 18, 2026NREPNEW REPRESENTATIVE AT IB RECEIVED—
Nov 19, 2025EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
Nov 19, 2025TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Nov 19, 2025ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
Nov 19, 2025ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 19, 2025REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Nov 19, 2025CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Nov 19, 2025COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Apr 4, 2025FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Mar 19, 2025FICSFINAL DISPOSITION NOTICE SENT TO IB—
Mar 19, 2025FIMPFINAL DISPOSITION PROCESSED—
Jan 17, 2025OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Jan 8, 2025FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jan 1, 2025OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Jan 1, 2025OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Oct 8, 2024NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Oct 8, 2024R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jul 23, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jul 23, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 3, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jun 14, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 14, 2024XAECEXAMINER'S AMENDMENT ENTERED—
Jun 14, 2024GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jun 14, 2024GNEAEXAMINERS AMENDMENT E-MAILED—
Jun 14, 2024CNEAEXAMINERS AMENDMENT -WRITTEN—
Jun 7, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 7, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 7, 2024TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 23, 2024RFNTREFUSAL PROCESSED BY IB—
Mar 30, 2024RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Mar 29, 2024RFRRREFUSAL PROCESSED BY MPU—
Mar 12, 2024RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Mar 11, 2024CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 5, 2024DOCKASSIGNED TO EXAMINER—
Aug 11, 2023MAFRAPPLICATION FILING RECEIPT MAILED—
Aug 7, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 4, 2023REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance